words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

Latest News

Stay up-to-date within the space.

Juniper_Announcement_Changes
Juniper Biologics Establishes Global Headquarters in Singapore 
legada2
Helsinn Healthcare SA signs exclusive license agreement with Juniper Biologics Pte. Ltd. for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
Juniper Biologics Healthcare Therapy Oncology Rare Orphan Diseases Gene Therapy Care Gene Therapy Post
Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets*